Inhibition of tumor progression using antisense oligonucleotide targeting Gli2 in androgen independent prostate cancer

被引：0
|
作者：
Narita, Shintaro
So, Alan I.
Sinnemann, Shannon
Fazli, Ladan
Marcusson, Eric G.
Gleave, Martin E.
机构：
来源：
JOURNAL OF UROLOGY | 2007年 / 177卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)30415-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [21] Antisense oligodeoxynucleotide therapy for prostate cancer targeting antiapoptotic genes involved in the mechanism mediating progression to androgen independence
    Miyake, Hideaki
    Hara, Isao
    Fujisawa, Masato
    Gleave, Martin E.
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2006, 1 (02) : 219 - 226
  • [22] Immune Modulation through Gli2 Targeting in Bone Metastatic Breast Cancer
    Bennett, Natalie
    Rhoades, Julie
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 123 - 123
  • [23] Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth
    Maresca, Luisa
    Crivaro, Enrica
    Migliorini, Francesca
    Anichini, Giulia
    Giammona, Alessandro
    Pepe, Sara
    Poggialini, Federica
    Vagaggini, Chaira
    Giannini, Giuseppe
    Sestini, Serena
    Borognoni, Lorenzo
    Lapucci, Andrea
    Dreassi, Elena
    Taddei, Maurizio
    Manetti, Fabrizio
    Petricci, Elena
    Stecca, Barbara
    PHARMACOLOGICAL RESEARCH, 2023, 195
  • [24] Therapeutic potential of combination therapy using a next generation antisense oligonucleotide targeting the androgen receptor and AKT inhibition with AZD5363 in genetically engineered mouse models of prostate cancer
    De Velasco, Marco A.
    Kura, Yurie
    Ando, Naomi
    Sugimoto, Koichi
    Sakai, Kazuko
    Davies, Barry R.
    Kim, Youngsoo
    MacLeod, A. Robert
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2017, 77
  • [25] TGF-β/SMAD/GLI2 Signaling Axis in Cancer Progression and Metastasis
    Javelaud, Delphine
    Alexaki, Vasileia I.
    Dennler, Sylviane
    Mohammad, Khalid S.
    Guise, Theresa A.
    Mauviel, Alain
    CANCER RESEARCH, 2011, 71 (17) : 5606 - 5610
  • [26] Novel therapeutic strategy for advanced prostate cancer using antisense oligodeoxynucleotides targeting anti-apoptotic genes upregulated after androgen withdrawal to delay androgen-independent progression and enhance chemosensitivity
    Miyake, H
    Hara, I
    Kamidon, S
    Gleave, ME
    INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (07) : 337 - 349
  • [27] Antisense TRPM-2 oligodeoxynucleotides delay progression to androgen independence and enhance chemosensitivity in prostate cancer tumor models.
    Miyake, H
    Chi, KN
    Gleave, ME
    CLINICAL CANCER RESEARCH, 1999, 5 : 3848S - 3848S
  • [28] Role of the endothelin axis in the progression to androgen independent prostate cancer
    Pflug, BR
    Dantonio, J
    Godara, G
    Nelson, JB
    JOURNAL OF UROLOGY, 2005, 173 (04): : 68 - 68
  • [29] Androgen-independent prostate cancer progression in the TRAMP model
    Gingrich, JR
    Barrios, RJ
    Kattan, MW
    Nahm, HS
    Finegold, MJ
    Greenberg, NM
    CANCER RESEARCH, 1997, 57 (21) : 4687 - 4691
  • [30] MMSET Is Associated with Prostate Cancer Progression and OverExpressed in Androgen Independent Metastatic Prostate Cancer
    Mehra, R.
    Asangani, I.
    Lonigro, R.
    Cao, X.
    Philips, N. E.
    Suleman, K.
    Varambally, S.
    Rubin, M. A.
    Shah, R. B.
    Pienta, K. J.
    Chinnaiyan, A. M.
    MODERN PATHOLOGY, 2011, 24 : 210A - 210A
12345